The management of exfoliative glaucoma

Progress in Brain Research

Volumn 173, Issue , 2008, Pages 211-224

  Ritch, Robert ^a  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

conformational disorder; exfoliation syndrome; exfoliative glaucoma; extracellular matrix; fibrillin; glaucoma; LOXL1

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; AGENTS ACTING ON THE EYE; AQUEOUS SUPPRESSANT; BIMATOPROST; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYTOCHALASIN B; EDETATE SODIUM; GLYCOCONJUGATE; LATANOPROST; LATRUNCULIN B; MIOTIC AGENT; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TRAVOPROST; UNCLASSIFIED DRUG;

ARGON LASER; CATARACT; CATARACT EXTRACTION; CLINICAL FEATURE; CLOSED ANGLE GLAUCOMA; DISEASE ASSOCIATION; ELASTIC FIBER; EXFOLIATION SYNDROME; EXTRACELLULAR MATRIX; GENE; HUMAN; LOXL1 GENE; NONHUMAN; OPEN ANGLE GLAUCOMA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETINA VEIN OCCLUSION; REVIEW; SCLERECTOMY; SINGLE NUCLEOTIDE POLYMORPHISM; TRABECULECTOMY; TRABECULOPLASTY; TRANSMISSION ELECTRON MICROSCOPY;

AMINO ACID OXIDOREDUCTASES; EXFOLIATION SYNDROME; GENETIC PREDISPOSITION TO DISEASE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE;

EID: 54749110232     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)01115-1     Document Type: Review

References (114)

1. Aasved H. The geographical distribution of fibrillopathia epitheliocapsularis. Acta Ophthalmol. 47 (1969) 792-810
2. Altintas O., Maral H., Yuksel N., Karabas V.L., Dillioglugil M.O., and Caglar Y. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 243 (2005) 677-683
3. Andrikopoulos G.K., Mela E.K., Georgakopoulos C.D., et al. Pseudoexfoliation syndrome prevalence in Greek patients with cataract and its association to glaucoma and coronary artery disease. Eye (2007) Epub Oct 12.
4. Aragon-Martin J.A., Ritch R., Liebmann J., O'Brien R., Blaaow K., Mercieca F., Spiteri A., Cobb C., Damji K., Tarkkanen A., Rezaie T., Child A., and Sarfarazi M. Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Mol. Vis. 14 (2008) 533-541
5. Aydogan Ozkan B., Yuksel N., Keskin G., et al. Homocysteine levels in plasma and sensorineural hearing loss in patients with pseudoexfoliation syndrome. Eur. J. Ophthalmol. 16 (2006) 542-547
6. Barkana Y., Anis S., Liebmann J.M., Tello C., and Ritch R. Intraocular pressure monitoring outside of normal office hours in patients with glaucoma is clinically useful. Arch. Ophthalmol. 124 (2006) 793-799
7. Becker B. Does hyposecretion of aqueous humor damage the trabecular meshwork? (editorial). J. Glaucoma 4 (1995) 303-305
8. Bedri A., and Alemu B. Pseudoexfoliation syndrome in Ethiopian glaucoma patients. East Afr. Med. J. 76 (1999) 278-280
9. Bengtsson B., and Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J. Glaucoma 14 (2005) 135-138
10. 2 EDTA and EGTA on aqueous outflow routes in the monkey eye. Invest. Ophthalmol. Vis. Sci. 19 (1980) 492-504
11. Bleich S., Roedl J., Von Ahsen N., Schlötzer-Schrehardt U., Reulbach U., Beck G., Kruse F.E., Naumann G.O.H., Kornhuber J., and Junemann A.G.M. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am. J. Ophthalmol. 138 (2004) 162-164
12. Cahill M., Early A., Stack S., Blayney A.W., and Eustace P. Pseudoexfoliation and sensorineural hearing loss. Eye 16 (2002) 261-266
13. Colin J., Le Gall G., Le Jeune B., et al. The prevalence of exfoliation syndrome in different areas of France. Acta Ophthalmol. 66 Suppl 184 (1988) 86-89
14. Cursiefen C., Hammer T., Küchle M., Naumann G.O.H., and Schlötzer-Schrehardt U. Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion. A histopathologic and electron microscopic study. Acta Ophthalmol. Scand. 79 (2001) 476-478
15. Drolsum L. Deep sclerectomy in patients with capsular glaucoma. Acta Ophthalmol. Scand. 81 (2003) 567-572
16. Drolsum L. Longterm follow-up after deep sclerectomy in patients with pseudoexfoliative glaucoma. Arch. Ophthalmol. Scand. 84 (2006) 502-506
17. Ethier C.R., Read A.T., and Chan D.W. Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1991-1998
18. Fingert J.H., Alward W.L., Kwon Y.H., Wang K., Streb L.M., Sheffield V.C., and Stone E.M. LOXL1 mutations are associated with exfoliation syndrome in patients from the Midwestern United States. Am. J. Ophthalmol. 144 (2007) 974-975
19. Gilad G.M., Kagan H.M., and Gilad V.H. Evidence for increased lysyl oxidase, the extracellular matrix-forming enzyme, in Alzheimer's disease brain. Neurosci. Lett. 376 (2005) 210-214
20. Gillies W.E. Trabeculotomy in pseudoexfoliation of the lens capsule. Br. J. Ophthalmol. 61 (1977) 297-305
21. Gracner T. Intraocular pressure response of capsular glaucoma and primary open angle glaucoma to selective Nd:YAG laser trabeculoplasty: a prospective, comparative clinical trial. Eur. J. Ophthalmol. 12 (2002) 287-292
22. Gradle H.S., and Sugar H.S. Glaucoma capsulare. Am. J. Ophthalmol. 30 (1947) 12-19
23. Hagadus R.J., Wandel T., Ritch R., et al. Pseudoexfoliation in patients with Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 30 Suppl (1989) 27
24. Hammer T., Schlötzer-Schrehardt U., and Naumann G.O.H. Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study. Arch. Ophthalmol. 119 (2001) 1023-1031
25. Harasymowicz P.J., Papamatheakis D.G., Latina M., de Leon M., Lesk M.R., and Damji K.F. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am. J. Ophthalmol. 139 6 (2005) 1110-1113
26. Harju M., and Vesti E. Blood flow of the optic nerve head and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension. Graefes Arch. Clin. Exp. Ophthalmol. 239 (2001) 271-277
27. Hayashi, H., Gotoh, N. and Ueda, Y. et al., (2008) Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. Am. J. Ophthalmol., Jan 15 Epub ahead of print.
28. Hewitt, A.W. et al., (2007) Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum. Mol. Genet., Nov. 23 Epub ahead of print.
29. Ho S.L., Dogar G.F., Wang J., et al. Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br. J. Ophthalmol. 89 (2005) 169-173
30. Holló G., Lakatos P., and Farkas K. Cold pressor test and plasma endothelin-1 concentration in primary open-angle glaucoma and capsular glaucoma. J. Glaucoma 7 (1998) 105-110
31. Holven K.B., Halvorsen B., Schulz H., et al. Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects. Scand. J. Clin. Lab. Invest. 66 (2006) 45-54
32. Honjo M., Tanihara H., Inatani M., et al. Phacoemulsification, intraocular lens implantation, and trabeculotomy to treat pseudoexfoliation syndrome. J. Cataract Refract. Surg. 24 (1998) 781-786
33. Horns D.J., et al. Argon laser trabeculoplasty for open angle glaucoma: a retrospective study of 380 eyes. Trans. Ophthalmol. Soc. UK 103 (1983) 288-294
34. Irkec M. Exfoliation and carotid stiffness (editorial). Br. J. Ophthalmol. 90 (2006) 529-530
35. Jacobi P.C., Dietlein T.S., and Krieglstein G.K. Bimanual trabecular aspiration in pseudoexfoliation glaucoma - an alternative in nonfiltering glaucoma surgery. Ophthalmology 105 (1998) 886-894
36. Jones W., White R.E., and Magnus D.E. Increased occurrence of exfoliation in the male, Spanish American population of New Mexico. J. Am. Optom. Assoc. 63 (1992) 643-648
37. Katula K.S., Heinloth A.N., and Paules R.S. Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. J. Nutr. Biochem. 18 (2007) 541-552
38. Kaufman P.L., and Bárány E.H. Cytochalasin B reversibly increases outflow facility in the eye of the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 16 (1977) 47-53
39. Kiland J.A., Miller C.L., Kim C.B., et al. Effect of H-7 and Lat-B on retinal physiology. Curr. Eye Res. 31 (2006) 441-455
40. Koliakos G.G., Konstas A.G.P., Schlötzer-Schrehardt U., et al. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am. J. Ophthalmol. 134 (2002) 879-883
41. Koliakos G.G., Konstas A.G.P., Schlötzer-Schrehardt U., et al. 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br. J. Ophthalmol. 87 (2003) 353-356
42. Koliakos G.G., Schlötzer-Schrehardt U., Konstas A.G., Bufidis T., Georgiadis N., and Dimitriadou A. Transforming and insulin like growth factor in the aqueous humor of patients with exfoliation syndrome. Graefes Arch. Clin. Exp. Ophthalmol. 239 (2001) 482-487
43. Konstas A.G.P., Holló G., Astakhov Y.S., et al. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch. Ophthalmol. 122 (2004) 29-33
44. Konstas A.G.P., Holló G., Irkec M., Tsironi S., Durukan I., Goldenfeld M., and Melamed S. Diurnal IOP control with bimatoprost vs latanoprost in exfoliative glaucoma: a crossover observer-masked 3-center study. Br. J. Ophthalmol. 91 (2007) 757-760
45. Konstas A.G.P., Koliakos G.G., Karabatsas C.H., et al. Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Exp. Eye Res. 82 (2006) 319-322
46. Konstas A.G.P., Kozobolis V.P., Katsimpris I.E., et al. Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients. Ophthalmology 114 (2007) 653-657
47. Konstas A.G.P., Topouzis F., Leliopoulou O., et al. 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma. Ophthalmology 113 (2006) 761-765
48. Kottler U.B., Jünemann A.G., Aigner T., Zenkel M., Rummelt C., and Schlötzer-Schrehardt U. Comparative effects of TGF-beta1 and TGF-beta2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp. Eye Res. 80 (2005) 121-134
49. Kozart D.M., and Yanoff M. Intraocular pressure status in 100 consecutive patients with exfoliation syndrome. Ophthalmology 89 (1982) 214-218
50. Kozobolis V.P., Papatzanaki M., Vlachonikolis I.G., Pallikaris I.G., and Tsambarlakis I.G. Epidemiology of pseudoexfoliation in the island of Crete (Greece). Acta Ophthalmol. 75 (1997) 726-729
51. Kuhlenbaumer G., Friedrichs F., Kis B., et al. Association between single nucleotide polymorphisms in the lysyl oxidase-like 1 gene and spontaneous cervical artery dissection. Cerebrovasc. Dis. 24 (2007) 343-348
52. Laatikainen L. Fluorescein angiographic studies of the peripapillary and perilimbal regions in simple, capsular and low-tension glaucoma. Acta Ophthalmol. III Suppl. (1971) 3-83
53. Leibovitch I., Kurtz S., Shemesh G., et al. Hyperhomocystinemia in pseudoexfoliation glaucoma. J. Glaucoma 12 (2003) 36-39
54. Leske M.C., Heijl A., Hussein M., et al. Factors for glaucoma progression and the effect of treatment. The Early Manifest Glaucoma Trial. Arch. Ophthalmol. 121 (2003) 48-56
55. Lewis C.M., Smith A.K., and Kamen B.A. Receptor-mediated folate uptake is positively regulated by disruption of the actin cytoskeleton. Cancer Res. 15 (1998) 2952-2956
56. Linnér E., Popovic V., Gottfries C.G., et al. The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmol. Scand. 79 (2001) 283-285
57. Liu X., Zhao Y., Gao J., et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat. Genet. 36 (2004) 178-182
58. Lobo A., Naso A., Arheart K., et al. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12. Am. J. Cardiol. 83 (1999) 821-825
59. Massé P.G., Yamauchi M., Mahuren J.D., et al. Connective tissue integrity is lost in vitamin B-6-deficient chicks. J. Nutr. 125 (1995) 26-34
60. Merrill A.H., and Henderson M. Diseases associated with defects in vitamin B6 metabolism or utilization. Annu. Rev. Nutr. 7 (1987) 137-156
61. Mitchell P., Wang J.J., and Hourihan F. The relationship between glaucoma and pseudoexfoliation: the Blue Mountains Eye Study. Arch. Ophthalmol. 117 (1999) 1319-1328
62. Mitchell P., Wang J.J., and Smith W. Association of pseudoexfoliation with increased vascular risk. Am. J. Ophthalmol. 124 (1997) 685-687
63. Moreno Montañés J., Alcolea Paredes A., and Campos García S. Prevalence of pseudoexfoliation syndrome in the northwest of Spain. Acta Ophthalmol. 67 (1989) 383-385
64. Naumann G.O.H., Schlötzer-Schrehardt U., and Küchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist: intraocular and systemic manifestations. Ophthalmology 105 (1998) 951-968
65. Odberg T., and Sandvik L. The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open-angle glaucoma. Acta Ophthalmol. 77 (1999) 176-181
66. Okka M., Tian B., and Kaufman P.L. Effect of low-dose latrunculin B on anterior segment physiologic features in the monkey. Arch. Ophthalmol. 122 (2004) 1482-1488
67. Oleggini R., Gastaldo N., and Di Donato A. Regulation of elastin promoter by lysyl oxidase and growth factors: cross control of lysyl oxidase on TGF-beta1 effects. Matrix Biol. 26 (2007) 494-505
68. Ovodenko B., Rostagno A., Neubert T.A., et al. Proteomic analysis of lenticular exfoliation deposits. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1447-1457
69. Peterson J.A., Tian B., Geiger B., and Kaufman P.L. Effect of latrunculin-B on outflow facility in monkeys. Exp. Eye Res. 70 (2000) 307-314
70. Prince A.M., and Ritch R. Clinical signs of the pseudoexfoliation syndrome. Ophthalmology 93 (1986) 803-807
71. Prince A.M., Streeten B.W., Ritch R., Dark A.J., and Sperling M. Preclinical diagnosis of pseudoexfoliation syndrome. Arch. Ophthalmol. 105 (1987) 1076-1082
72. Puska P., Vesti E., Tomita G., Ishida K., and Raitta C. Optic disc changes in normotensive persons with unilateral exfoliation syndrome: a 3-year follow-up study. Graefes Arch. Clin. Exp. Ophthalmol. 237 (1999) 457-462
73. Puustjärvi T., Blomster H., Kontkanen M., et al. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefe's Arch. Clin. Exp. Ophthalmol. 242 (2004) 749-754
74. Raposo B., Rodriguez C., Martínez-Gonzáles J., and Badimon L. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells. Atherosclerosis 177 (2004) 1-8
75. Rekonen P., Kannisto T., Puustjärvi T., et al. Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma. Arch. Ophthalmol. Scand. 84 (2006) 507-511
76. Repo L.P., Suhonen M.T., Teräsvirta M.E., and Koivisto J.K. Color Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischemic attack. Correlations with generalized iris transluminance and pseudoexfoliation syndrome. Ophthalmology 102 (1995) 1199-1205
77. Ringvold A., Blika S., Elsås T., et al. The middle-Norway eye-screening study. I. Epidemiology of the pseudo-exfoliation syndrome. Acta Ophthalmol. 66 (1988) 652-657
78. Ritch R. Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma. J. Glaucoma 3 (1994) 176-178
79. Ritch R., and Podos S.M. Laser trabeculoplasty in exfoliation syndrome. Bull. N.Y. Acad. Med. 59 (1983) 339-344
80. Ritch R., and Schlötzer-Schrehardt U. Exfoliation syndrome. Surv. Ophthalmol. 45 (2001) 265-315
81. Ritch R., Schlötzer-Schrehardt U., and Konstas A.G.P. Why is glaucoma associated with exfoliation syndrome?. Prog. Retinal Eye Res. 22 (2003) 253-275
82. Rodríguez, C., Alcudia, J.F. and Martínez-González, J. et al., 2007. Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction. Atherosclerosis, Epub ahead of print.
83. Roedl J.B., Bleich S., Reulbach U., et al. Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J. Glaucoma 16 (2007) 234-239
84. Roedl J.B., Bleich S., Reulbach U., et al. Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J. Neural. Transm. 114 (2007) 571-575
85. Rönkkö S., Rekonen P., Kaarniranta K., et al. Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefe's Arch. Clin. Exp. Ophthalmol. 245 (2007) 697-704
86. Roth M., and Epstein D.L. Exfoliation syndrome. Am. J. Ophthalmol. 89 (1980) 477-486
87. Saatci O.A., Ferliel S.T., Ferliel M., et al. Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion. Int. Ophthalmol. 23 (1999) 75-78
88. Sabanay I., Tian B., Gabelt B.A.T., et al. Latrunculin B effects on trabecular meshwork and corneal endothelial morphology in monkeys. Exp. Eye Res. 82 (2006) 236-246
89. Schlötzer-Schrehardt U., Koca M.R., Naumann G.O.H., and Volkholz H. Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder?. Arch. Ophthalmol. 110 (1992) 1752-1756
90. Schlötzer-Schrehardt U., Küchle M., Dorfler S., and Naumann G.O.H. Pseudoexfoliative material in the eyelid skin of pseudoexfoliation-suspect patients: a clinico-histopathological correlation. German J. Ophthalmol. 2 (1993) 51-60
91. Schlötzer-Schrehardt U., Küchle M., Rummelt C., and Naumann G.O.H. Role of transforming growth factor-b and its latent form binding protein in pseudoexfoliation syndrome. Invest. Ophthalmol. Vis. Sci. 40 (1999) S278
92. Schlötzer-Schrehardt U., Lommatzsch J., Küchle M., Konstas A.G.P., and Naumann G.O.H. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1117-1125
93. Schlötzer-Schrehardt U., and Naumann G.O.H. Ocular and systemic pseudoexfoliation syndrome. Am. J. Ophthalmol. 141 (2006) 921-937
94. Scullica L., Buceti R., Castagna I., Ferreri G., and Trombetta C.J. Functional aspects of pseudoexfoliation: physiopathological features. New Trends Ophthalmol. 8 (1993) 163-168
95. Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J. Nutr. 136 6 Suppl. (2006) 1726S-1730S
96. Shaban R.I., and Asfour W.M. Ocular pseudoexfoliation associated with hearing loss. Saudi Med. J. 25 (2004) 1254-1257
97. Shakya S., Koirala S., and Karmacharya P.C.D. Pseudoexfoliation syndrome in Nepal: a hospital-based retrospective study. Asia-Pacific J. Ophthalmol. 16 (2004) 13-16
98. Shimizu K., Kimura Y., and Aoki K. Prevalence of exfoliation syndrome in the Japanese. Acta Ophthalmol. 66 Suppl 184 (1988) 112-115
99. Sibour G., Finazzo C., and Boles Carenini A. Monolateral pseudoexfoliatio capsulae: a study of choroidal blood flow. Acta Ophthalmol. Scand. 75 Suppl 224 (1997) 13-14
100. Starcher B., and Hill C.H. Elastin defects in the lungs of avian and murine models of homocysteinemia. Exp. Lung Res. 31 (2005) 873-885
101. Streeten B.W., Gibson S.A., and Dark A.J. Pseudoexfoliative material contains an elastic microfibrillar-associated glycoprotein. Trans. Am. Ophthalmol. Soc. 84 (1986) 304-320
102. Streeten B.W., Li Z.Y., Wallace R.N., Eagle R.C.J., and Keshgegian A.A. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch. Ophthalmol. 110 (1992) 1757-1762
103. Tanihara H., Negi A., Akimoto M., Terauchi H., Okudaira A., Kozaki J., Takeuchi A., and Nagata M. Surgical effect of trabeculotomy ab externo on adult eyes with primary open angle glaucoma and pseudoexfoliation syndrome. Arch. Ophthalmol. 111 (1993) 1653-1661
104. Thorliefsson G., Magnusson K.P., Sulem P., et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 317 (2007) 1397-1400
105. Tian B., Kaufman P.L., Volberg T., Gabelt B.T., and Geiger B. H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch. Ophthalmol. 116 (1998) 633-643
106. Tian B., Gabelt B.T., Geiger B., and Kaufman P.L. Combined effects of H-7 and cytochalasin B on outflow facility in monkeys. Exp. Eye Res. 68 (1999) 649-655
107. Vessani R.M., Liebmann J.M., Jofe M., and Ritch R. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am. J. Ophthalmol. 136 (2003) 41-46
108. Visontai Z., Merisch B.M., Kollai M., and Hollo G. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br. J. Ophthalmol. 360-367 (2006) 90
109. Yilmaz A., Adiguzel U., Tamer L., et al. Serum oxidant/antioxidant balance in exfoliation syndrome. Clin. Experiment. Ophthalmol. 33 (2005) 63-66
110. Yüksel N., Anik Y., Kilic A., Karabas V., Demirci A., and Caglar Y. Cerebrovascular blood flow velocities in pseudoexfoliation. Graefes Arch. Clin. Exp. Ophthalmol. 244 (2006) 316-321
111. Yüksel N., Karabas V.L., Arslan A., et al. Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 108 (2001) 1043-1049
112. Zee R.Y., Mora S., et al. Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin. Chem. 53 (2007) 845-851
113. Zenkel M., Kruse F.E., Jünemann A.G., Naumann G.O.H., and Schlötzer-Schrehardt U. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1982-1990
114. Zenkel M., Pöschl E., von der Mark K., Carmen Hofmann-Rummelt C., Naumann G.O.H., Kruse F.E., and Schlötzer-Schrehardt U. Differential gene expression in pseudoexfoliation syndrome. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3742-3752